QUINCE THERAPEUTICS INC
Q2 2026 13F Holders
Symbol
IRLA
CUSIP
22053A305
Type
Equity
Class
COM
Num filings
30
Total reported value, excl. options
$17.3 M
Compare 2026 Q2 to
2026 Q3
Manager
Report Date
Value ($000)
Shares
Option Type